226 related articles for article (PubMed ID: 20692050)
1. Association to the Glypican-5 gene in multiple sclerosis.
Lorentzen AR; Melum E; Ellinghaus E; Smestad C; Mero IL; Aarseth JH; Myhr KM; Celius EG; Lie BA; Karlsen TH; Franke A; Harbo HF
J Neuroimmunol; 2010 Sep; 226(1-2):194-7. PubMed ID: 20692050
[TBL] [Abstract][Full Text] [Related]
2. Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis.
Nischwitz S; Cepok S; Kroner A; Wolf C; Knop M; Müller-Sarnowski F; Pfister H; Roeske D; Rieckmann P; Hemmer B; Ising M; Uhr M; Bettecken T; Holsboer F; Müller-Myhsok B; Weber F
J Neuroimmunol; 2010 Oct; 227(1-2):162-6. PubMed ID: 20598377
[TBL] [Abstract][Full Text] [Related]
3. Putative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases.
Shin JG; Kim HJ; Park BL; Bae JS; Kim LH; Cheong HS; Shin HD
J Neurol Sci; 2013 Dec; 335(1-2):82-8. PubMed ID: 24135429
[TBL] [Abstract][Full Text] [Related]
4. Glypican 5 is an interferon-beta response gene: a replication study.
Cénit MD; Blanco-Kelly F; de las Heras V; Bartolomé M; de la Concha EG; Urcelay E; Arroyo R; Martínez A
Mult Scler; 2009 Aug; 15(8):913-7. PubMed ID: 19556317
[TBL] [Abstract][Full Text] [Related]
5. The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility.
Bahreini SA; Jabalameli MR; Saadatnia M; Zahednasab H
J Neuroimmunol; 2010 Dec; 229(1-2):5-15. PubMed ID: 20832869
[TBL] [Abstract][Full Text] [Related]
6. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.
Rubio JP; Stankovich J; Field J; Tubridy N; Marriott M; Chapman C; Bahlo M; Perera D; Johnson LJ; Tait BD; Varney MD; Speed TP; Taylor BV; Foote SJ; Butzkueven H; Kilpatrick TJ
Genes Immun; 2008 Oct; 9(7):624-30. PubMed ID: 18650830
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association analysis in primary sclerosing cholangitis.
Karlsen TH; Franke A; Melum E; Kaser A; Hov JR; Balschun T; Lie BA; Bergquist A; Schramm C; Weismüller TJ; Gotthardt D; Rust C; Philipp EE; Fritz T; Henckaerts L; Weersma RK; Stokkers P; Ponsioen CY; Wijmenga C; Sterneck M; Nothnagel M; Hampe J; Teufel A; Runz H; Rosenstiel P; Stiehl A; Vermeire S; Beuers U; Manns MP; Schrumpf E; Boberg KM; Schreiber S
Gastroenterology; 2010 Mar; 138(3):1102-11. PubMed ID: 19944697
[TBL] [Abstract][Full Text] [Related]
8. More CLEC16A gene variants associated with multiple sclerosis.
Nischwitz S; Cepok S; Kroner A; Wolf C; Knop M; Müller-Sarnowski F; Pfister H; Rieckmann P; Hemmer B; Ising M; Uhr M; Bettecken T; Holsboer F; Müller-Myhsok B; Weber F
Acta Neurol Scand; 2011 Jun; 123(6):400-6. PubMed ID: 20849399
[TBL] [Abstract][Full Text] [Related]
9. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis.
Hoppenbrouwers IA; Aulchenko YS; Janssens AC; Ramagopalan SV; Broer L; Kayser M; Ebers GC; Oostra BA; van Duijn CM; Hintzen RQ
J Hum Genet; 2009 Nov; 54(11):676-80. PubMed ID: 19834503
[TBL] [Abstract][Full Text] [Related]
10. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
Burfoot RK; Jensen CJ; Field J; Stankovich J; Varney MD; Johnson LJ; Butzkueven H; Booth D; Bahlo M; Tait BD; Taylor BV; Speed TP; Heard R; Stewart GJ; Foote SJ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2008 Jan; 71(1):42-50. PubMed ID: 17971048
[TBL] [Abstract][Full Text] [Related]
11. Risk alleles for multiple sclerosis in multiplex families.
D'Netto MJ; Ward H; Morrison KM; Ramagopalan SV; Dyment DA; DeLuca GC; Handunnetthi L; Sadovnick AD; Ebers GC
Neurology; 2009 Jun; 72(23):1984-8. PubMed ID: 19506219
[TBL] [Abstract][Full Text] [Related]
12. EVI5 is a risk gene for multiple sclerosis.
Hoppenbrouwers IA; Aulchenko YS; Ebers GC; Ramagopalan SV; Oostra BA; van Duijn CM; Hintzen RQ
Genes Immun; 2008 Jun; 9(4):334-7. PubMed ID: 18401352
[TBL] [Abstract][Full Text] [Related]
13. A new association between polymorphisms of the SLC6A7 gene in the chromosome 5q31-32 region and asthma.
Kim JH; Cheong HS; Park BL; Bae JS; Jung S; Yoon SH; Park JS; Jang AS; Park SW; Uh ST; Kim YH; Hwang HK; Park CS; Shin HD
J Hum Genet; 2010 Jun; 55(6):358-65. PubMed ID: 20431603
[TBL] [Abstract][Full Text] [Related]
14. Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression.
Kantarci OH; Hebrink DD; Schaefer-Klein J; Sun Y; Achenbach S; Atkinson EJ; Heggarty S; Cotleur AC; de Andrade M; Vandenbroeck K; Pelfrey CM; Weinshenker BG
Arch Neurol; 2008 Mar; 65(3):349-57. PubMed ID: 18332247
[TBL] [Abstract][Full Text] [Related]
15. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.
Harbo HF; Lie BA; Sawcer S; Celius EG; Dai KZ; Oturai A; Hillert J; Lorentzen AR; Laaksonen M; Myhr KM; Ryder LP; Fredrikson S; Nyland H; Sørensen PS; Sandberg-Wollheim M; Andersen O; Svejgaard A; Edland A; Mellgren SI; Compston A; Vartdal F; Spurkland A
Tissue Antigens; 2004 Mar; 63(3):237-47. PubMed ID: 14989713
[TBL] [Abstract][Full Text] [Related]
16. Linkage disequilibrium analyses within chromosome 19p in multiple sclerosis.
Vyshkina T; Kalman B
Mult Scler; 2008 May; 14(4):433-9. PubMed ID: 18208878
[TBL] [Abstract][Full Text] [Related]
17. Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes.
Cortes A; Field J; Glazov EA; Hadler J; ; Stankovich J; Brown MA
Hum Mol Genet; 2013 Jun; 22(11):2283-92. PubMed ID: 23406874
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.
Byun E; Caillier SJ; Montalban X; Villoslada P; Fernández O; Brassat D; Comabella M; Wang J; Barcellos LF; Baranzini SE; Oksenberg JR
Arch Neurol; 2008 Mar; 65(3):337-44. PubMed ID: 18195134
[TBL] [Abstract][Full Text] [Related]
19. Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences.
Kochi Y; Yamada R; Kobayashi K; Takahashi A; Suzuki A; Sekine A; Mabuchi A; Akiyama F; Tsunoda T; Nakamura Y; Yamamoto K
Arthritis Rheum; 2004 Jan; 50(1):63-71. PubMed ID: 14730600
[TBL] [Abstract][Full Text] [Related]
20. Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients.
Weber F; Cepok S; Wolf C; Berthele A; Uhr M; Bettecken T; Buck D; Hartung HP; Holsboer F; Müller-Myhsok B; Hemmer B
Pharmacogenomics J; 2012 Jun; 12(3):238-45. PubMed ID: 21502966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
